rvine drug developer Spectrum Pharmaceuticals Inc. topped Wall Street projections with fourth-quarter results released earlier this month. The cancer drug maker earned $4.4 million in the quarter, ...
Irvine drug maker Spectrum Pharmaceuticals Inc. on Wednesday forecast better-than-expected results for the first quarter. Spectrum said in a preview that its quarterly product sales, which are less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results